Javier Llorca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Javier Llorca has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Trinidad Dierssen-Sotos
Preventive Medicine Group, University of Cantabria, IDIVAL-Valdecilla Health Research Institute, Santander, Spain; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
4 shared publications - Alba Marcos-Delgado
Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain
2 shared publications - Beatriz Arbaizar
Unit of Mental Health, Hospital de Laredo, Laredo, Spain
2 shared publications D Prieto Salceda
2 shared publicationsDolores Prieto Salceda
2 shared publications- Inés Gómez-Acebo
Department of Preventive Medicine and Public Health, University of Cantabria, Santander, Spain
2 shared publications
Latest Publications
- 31 August 2010
- Published by Elsevier in General Hospital Psychiatry
- Vol. 32 (4) , 449
Comments on “Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.” Authors' response
- 31 August 2010
- Published by Elsevier in General Hospital Psychiatry
- Vol. 32 (4) , 449
Comments on “Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.” Authors' response
- 31 October 2009
- Published by Elsevier in General Hospital Psychiatry
- Vol. 31 (5) , 478-483
Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials
- 31 October 2009
- Published by Elsevier in General Hospital Psychiatry
- Vol. 31 (5) , 478-483
Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials
- 1 June 2009
- Published by Elsevier in Revista de Calidad Asistencial
- Vol. 24 (3) , 104-108
Diferencias en la satisfacción percibida según el sexo en los pacientes ingresados en los hospitales del Servicio Cántabro de Salud
- 1 June 2009
- Published by Elsevier in Revista de Calidad Asistencial
- Vol. 24 (3) , 104-108
Diferencias en la satisfacción percibida según el sexo en los pacientes ingresados en los hospitales del Servicio Cántabro de Salud
- Open Access
- 1 December 2004
- Published by FapUNIFESP (SciELO) in Revista Espanola de Salud Publica
- Vol. 78 (6) , 709-712
Influencia de la población estándar sobre las tasas de mortalidad ajustadas por edad: el ejemplo del cáncer de cérvix en España
- 1 December 2004
- Published by FapUNIFESP (SciELO) in Revista Espanola de Salud Publica
- Vol. 78 (6) , 709-712
Open AccessInfluencia de la población estándar sobre las tasas de mortalidad ajustadas por edad: el ejemplo del cáncer de cérvix en España
- Open Access
- 1 February 2001
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 30 (1) , 99-101
Competing risks analysis using Markov chains: impact of cerebrovascular and ischaemic heart disease in cancer mortality
Background A decrease in cerebrovascular disease (CVD) and ischaemic heart disease (IHD) mortality can produce an increase in mortality from other causes, even cancer. This problem is called the competing risks problem. Methods A Markov chain is used to analyse the interrelation between CVD, IHD and cancer mortalities in Spanish women in 1981 and 1994. We compare the results using two models: discarding CVD and IHD mortality (the elimination model) and substituting CVD and IHD 1981 mortality rates in 1994 figures (the constant model). Results Removing mortality from CVD and IHD increases cancer mortality rates in women aged ≥70, and the probability of death from cancer rises from 10.7% to 13.3%. In the second model, the use of CVD and IHD 1981 mortality rates in 1994 data yields slightly lower mortality rates and so the impact of CVD and IHD mortality changes in the period 1981 to 1994 is negligible except in elderly women. Conclusions Although IHD and CVD mortality have decreased in all age groups of Spanish women from 1981 to 1994, this has not had a great impact on cancer mortality.
- 1 February 2001
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 30 (1) , 99-101
Open AccessCompeting risks analysis using Markov chains: impact of cerebrovascular and ischaemic heart disease in cancer mortality
Background A decrease in cerebrovascular disease (CVD) and ischaemic heart disease (IHD) mortality can produce an increase in mortality from other causes, even cancer. This problem is called the competing risks problem. Methods A Markov chain is used to analyse the interrelation between CVD, IHD and cancer mortalities in Spanish women in 1981 and 1994. We compare the results using two models: discarding CVD and IHD mortality (the elimination model) and substituting CVD and IHD 1981 mortality rates in 1994 figures (the constant model). Results Removing mortality from CVD and IHD increases cancer mortality rates in women aged ≥70, and the probability of death from cancer rises from 10.7% to 13.3%. In the second model, the use of CVD and IHD 1981 mortality rates in 1994 data yields slightly lower mortality rates and so the impact of CVD and IHD mortality changes in the period 1981 to 1994 is negligible except in elderly women. Conclusions Although IHD and CVD mortality have decreased in all age groups of Spanish women from 1981 to 1994, this has not had a great impact on cancer mortality.
- Open Access
- 1 January 2001
- Published by Elsevier in Gaceta Sanitaria
- Vol. 15 (1) , 61-67
Fracción atribuible poblacional: cálculo e interpretación
- 1 January 2001
- Published by Elsevier in Gaceta Sanitaria
- Vol. 15 (1) , 61-67
Open AccessFracción atribuible poblacional: cálculo e interpretación
- 30 November 2000
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 53 (11) , 1145-1149
Competing risks in absence of independence:: Impact of AIDS on liver function failure mortality, and lung cancer on ischemic heart disease mortality
- 30 November 2000
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 53 (11) , 1145-1149
Competing risks in absence of independence:: Impact of AIDS on liver function failure mortality, and lung cancer on ischemic heart disease mortality
- 14 October 2000
- Vol. 74 (4) , 341-50
[Comparison between several standard populations for age-adjusting].
To analyse the effect the choice of reference population has on different indicators derived from mortality rates age-adjusting. The mortality rates for different causes of death in Spain from 1971 to 1992 were adjusted by using four reference populations: Spanish populations from 1971 and 1992, the Standard European population and the standard world population. The results obtained with the four populations were compared by applying three indicators: difference between the rates of 1992 and 1971, ratio between the rates of 1992 and 1971 and annual percentage change between 1971 and 1992. In the majority of the causes of death studied, including the total, ischemic heart disease and almost all of the tumours, the ratio between the rates and the percentage of annual change are similar regardless of the standard population used. However, the difference in rates is very noticeable in relation to the reference population. In the infectious diseases and testis cancer, the opposite occurs: the different in rates is steadfast while the ratio between the rates varies with the standard population. Finally, the mortality due to pneumonia, Parkinson's disease and encephalic cancer show changes all three indicators used. An analysis of the specific rates by age must be made before proceeding with their adjustment. This analysis will enable us to ascertain whether the adjustment by age is correct and which indicator (difference, ratio or percentage change) will be appropriate for making comparisons.
- 14 October 2000
- Vol. 74 (4) , 341-50
[Comparison between several standard populations for age-adjusting].
To analyse the effect the choice of reference population has on different indicators derived from mortality rates age-adjusting. The mortality rates for different causes of death in Spain from 1971 to 1992 were adjusted by using four reference populations: Spanish populations from 1971 and 1992, the Standard European population and the standard world population. The results obtained with the four populations were compared by applying three indicators: difference between the rates of 1992 and 1971, ratio between the rates of 1992 and 1971 and annual percentage change between 1971 and 1992. In the majority of the causes of death studied, including the total, ischemic heart disease and almost all of the tumours, the ratio between the rates and the percentage of annual change are similar regardless of the standard population used. However, the difference in rates is very noticeable in relation to the reference population. In the infectious diseases and testis cancer, the opposite occurs: the different in rates is steadfast while the ratio between the rates varies with the standard population. Finally, the mortality due to pneumonia, Parkinson's disease and encephalic cancer show changes all three indicators used. An analysis of the specific rates by age must be made before proceeding with their adjustment. This analysis will enable us to ascertain whether the adjustment by age is correct and which indicator (difference, ratio or percentage change) will be appropriate for making comparisons.
- Open Access
- 1 August 2000
- Published by FapUNIFESP (SciELO) in Revista Espanola de Salud Publica
- Vol. 74 (4) , 00
Comparación entre varias poblaciones estándar para el ajuste por edades
FUNDAMENTO: Analizar el efecto que tiene la elección de una población de referencia sobre diferentes indicadores derivados de las tasas de mortalidad ajustadas por edad. MÉTODOS: Las tasas de mortalidad por diferentes causas de muerte en España de 1971 a 1992 son ajustadas empleando cuatro poblaciones de referencia: poblaciones españolas de 1971 y 1992, población estándar europea y población estándar mundial. Los resultados obtenidos con las cuatro poblaciones se comparan empleando tres indicadores: diferencia entre las tasas de 1992 y 1971, razón entre las tasas de 1992 y 1971y cambio anual porcentual entre 1971 y 1992. RESULTADOS: En la mayor parte de las causas de muerte estudiadas incluyendo el total de causas, la cardiopatía isquémica y casi todos los tumores, la razón de tasas y el porcentaje de cambio anual son similares con independencia de cuál sea la población estándar empleada. En cambio, la diferencia de tasas es muy diferente en función de la población de referencia. En las enfermedades infecciosas y el cáncer de testículo se produce la situación contraria: la diferencia de tasas es robusta mientras que la razón de tasas varía con la población estándar. Finalmente, la mortalidad por neumonía, enfermedad de Parkinson y cáncer de encéfalo muestra cambios en los tres indicadores utilizados. CONCLUSIONES: Es necesario realizar un análisis de las tasas específicas por edad antes de proceder a su ajuste. Este análisis permite averiguar si el ajuste por edades es correcto y qué indicador (diferencia, razón o cambio porcentual) será adecuado para realizar comparaciones.
- 1 August 2000
- Published by FapUNIFESP (SciELO) in Revista Espanola de Salud Publica
- Vol. 74 (4) , 00
Open AccessComparación entre varias poblaciones estándar para el ajuste por edades
FUNDAMENTO: Analizar el efecto que tiene la elección de una población de referencia sobre diferentes indicadores derivados de las tasas de mortalidad ajustadas por edad. MÉTODOS: Las tasas de mortalidad por diferentes causas de muerte en España de 1971 a 1992 son ajustadas empleando cuatro poblaciones de referencia: poblaciones españolas de 1971 y 1992, población estándar europea y población estándar mundial. Los resultados obtenidos con las cuatro poblaciones se comparan empleando tres indicadores: diferencia entre las tasas de 1992 y 1971, razón entre las tasas de 1992 y 1971y cambio anual porcentual entre 1971 y 1992. RESULTADOS: En la mayor parte de las causas de muerte estudiadas incluyendo el total de causas, la cardiopatía isquémica y casi todos los tumores, la razón de tasas y el porcentaje de cambio anual son similares con independencia de cuál sea la población estándar empleada. En cambio, la diferencia de tasas es muy diferente en función de la población de referencia. En las enfermedades infecciosas y el cáncer de testículo se produce la situación contraria: la diferencia de tasas es robusta mientras que la razón de tasas varía con la población estándar. Finalmente, la mortalidad por neumonía, enfermedad de Parkinson y cáncer de encéfalo muestra cambios en los tres indicadores utilizados. CONCLUSIONES: Es necesario realizar un análisis de las tasas específicas por edad antes de proceder a su ajuste. Este análisis permite averiguar si el ajuste por edades es correcto y qué indicador (diferencia, razón o cambio porcentual) será adecuado para realizar comparaciones.
- 1 June 2000
- Vol. 74 (1) , 5-12
[The measurement of inequalities in age of death: calculating the Gini Index based on mortality tables].
The Gini index has been used to gauge the concentration of different variables, including income, the mortality distribution and the spread of physicians. The use of the Gini index for gauging the inequalities in the age of death based on actuarial mortality data. For this purpose, the 1990 age and gender-related mortality figures for each Autonomous Community were used. The inequalities in the number of years lived are greater among males than among females throughout all of the Autonomous Communities. The Communities showing the longest life expectancies are those which have also been revealed to involved the least degree of inequality in the number of years lived, which therefore makes in possible to pinpoint health-care priorities in some cases. The Gini index can be applied to age-related mortality for gauging the degree of inequality in the age of death and to pinpoint age groups on which to place priority with regard to health-care measures.
- 1 June 2000
- Vol. 74 (1) , 5-12
[The measurement of inequalities in age of death: calculating the Gini Index based on mortality tables].
The Gini index has been used to gauge the concentration of different variables, including income, the mortality distribution and the spread of physicians. The use of the Gini index for gauging the inequalities in the age of death based on actuarial mortality data. For this purpose, the 1990 age and gender-related mortality figures for each Autonomous Community were used. The inequalities in the number of years lived are greater among males than among females throughout all of the Autonomous Communities. The Communities showing the longest life expectancies are those which have also been revealed to involved the least degree of inequality in the number of years lived, which therefore makes in possible to pinpoint health-care priorities in some cases. The Gini index can be applied to age-related mortality for gauging the degree of inequality in the age of death and to pinpoint age groups on which to place priority with regard to health-care measures.